XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
  AIDS
  Influenza
  MRSA
  Tuberculosis
  Shigella
  HCV
  SARS
  Ebola
  Dengue
  Malaria
   Plasmodium
  Pertussis
  Mumps
  Prion Diseases
  Small Pox
  Anthrax
  Leishmaniasis
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Malaria Channel
subscribe to Malaria newsletter

Latest Research : Infectious Diseases : Malaria

   DISCUSS   |   EMAIL   |   PRINT
Drug Combo Against AIDS-Related Infections Also Prevents Malaria
Oct 19, 2005 - 8:55:00 PM, Reviewed by: Dr.

�based on the results of this study and the clear evidence that TS prevents death in persons living with HIV in a variety of African settings, concerns about spreading SP resistance do not justify further delays in implementing TS prophylaxis�

 
A drug combination used to prevent pneumonia and opportunistic bacterial infection in persons with HIV/AIDS has unexpectedly been found to be highly effective at preventing malaria, according to a study published in the November 15 issue of The Journal of Infectious Diseases, now available online.

The combination, trimethoprim-sulfamethoxazole (TS), is known to reduce morbidity and mortality from certain opportunistic infections in HIV-infected individuals, and is widely recommended for individuals with advanced disease, both in developed and developing countries. In addition, TS shares many properties--including resistance patterns--with a leading anti-malarial therapy, sulfadoxine-pyrimethamine (SP), causing concern that widespread use of TS prophylaxis might increase the number of malarial parasite strains resistant to SP treatment, thereby increasing the risk that SP treatment may fail in HIV-infected individuals who contract malaria.

These concerns prompted Christopher V. Plowe, MD, MPH, and colleagues at the University of Maryland School of Medicine and the Malaria Research and Training Center at the University of Bamako to conduct a study to determine whether TS prophylaxis impairs SP efficacy for treating malaria. The investigators studied 160 children (aged 5-15 years) given TS prophylaxis and 80 children in a control group receiving no preventive treatment in Mali, where malaria is endemic and rates of HIV infection in children are low. Plowe and colleagues were expecting to compare the success of SP treatment on malarial episodes in both groups. What they encountered, however, was just a single clinical episode of malaria in the TS group, and the infected individual had an adequate clinical and parasitological response to SP. In the control group, there were 72 episodes of malaria and three instances of SP failure.

Lack of malarial episodes in the TS group precluded meaningful comparison of SP efficacy in the TS and control groups, but, importantly, TS was shown to be a highly effective prophylactic agent against malaria in this population, reducing the incidence by 99.5%.

In addition to being protected against malaria, children in the TS group also experienced fewer gastrointestinal illnesses and had slightly higher hemoglobin levels than those in the control group. The authors pointed out that such benefits did not mean that routine TS prophylaxis should be used in healthy children but that they did �mitigate concerns about TS use in HIV-exposed children whose HIV status is not yet known.�

Although the authors cautioned that studies of SP efficacy in persons taking TS prophylaxis are still needed and that SP should be used only with caution in those taking TS who contract malaria, �based on the results of this study and the clear evidence that TS prevents death in persons living with HIV in a variety of African settings, concerns about spreading SP resistance do not justify further delays in implementing TS prophylaxis.�
 

- November 15 issue of The Journal of Infectious Diseases
 

www.idsociety.org

 
Subscribe to Malaria Newsletter
E-mail Address:

 

Founded in 1904, The Journal of Infectious Diseases is the premier publication in the Western Hemisphere for original research on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms. Articles in JID include research results from microbiology, immunology, epidemiology, and related disciplines. JID is published under the auspices of the Infectious Diseases Society of America (IDSA). Based in Alexandria, Va., IDSA is a professional society representing about 8,000 physicians and scientists who specialize in infectious diseases. For more information, visit www.idsociety.org.

Related Malaria News

Retina can provide a very reliable way of diagnosing cerebral malaria
New findings could lead to vaccine for severe malaria
AgDscam gene Holds the Key to Broad-Based Pathogen Recognition
Genes responsible for malaria parasite's survival pin pointed
Mosquito immune system examined
The Haptoglobin Genotype Connection with Childhood Anemia in a Malaria-Endemic Region
Mosquitoes that could help combat malaria!
Malaria parasite plasmodium impairs key immune system cells
Modeling the Impact of Intermittent Preventative Treatment on the Spread of Drug-Resistant Malaria
Global warming trend may contribute to malaria's rise


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us